Tasca Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $67M

  • Investors
  • 7

Tasca Therapeutics General Information

Description

Developer of a drug discovery platform intended to develop small-molecule inhibitors for difficult-to-treat oncology indications. The company's platform utilizes mass spectrometry-based proteomics and proprietary reagents to identify and map novel lipid-binding pockets on auto-palmitoylated proteins, enabling clinicians to target previously undruggable cancer drivers with first-in-class small-molecule therapies.

Contact Information

Website
www.tascatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 55 Spinelli Place
  • Cambridge, MA 02138
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 55 Spinelli Place
  • Cambridge, MA 02138
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tasca Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 17-Sep-2025 $67M Completed Clinical Trials - Phase 1
To view Tasca Therapeutics’s complete valuation and funding history, request access »

Tasca Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Series A-1
To view Tasca Therapeutics’s complete cap table history, request access »

Tasca Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tasca Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
8VC Venture Capital Minority
AB Magnitude Ventures Group Venture Capital Minority
Cure Ventures Venture Capital Minority
Invus (Private Equity) PE/Buyout Minority
Regeneron Ventures Corporate Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Tasca Therapeutics FAQs

  • When was Tasca Therapeutics founded?

    Tasca Therapeutics was founded in 2022.

  • Where is Tasca Therapeutics headquartered?

    Tasca Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Tasca Therapeutics?

    Tasca Therapeutics has 23 total employees.

  • What industry is Tasca Therapeutics in?

    Tasca Therapeutics’s primary industry is Drug Discovery.

  • Is Tasca Therapeutics a private or public company?

    Tasca Therapeutics is a Private company.

  • What is the current valuation of Tasca Therapeutics?

    The current valuation of Tasca Therapeutics is .

  • What is Tasca Therapeutics’s current revenue?

    The current revenue for Tasca Therapeutics is .

  • How much funding has Tasca Therapeutics raised over time?

    Tasca Therapeutics has raised $67M.

  • Who are Tasca Therapeutics’s investors?

    8VC, AB Magnitude Ventures Group, Cure Ventures, Invus (Private Equity), and Regeneron Ventures are 5 of 7 investors who have invested in Tasca Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process